Optimizing CLL Care and Quality of Life with Patient-Centered Strategies
Charles Turck, PharmD, BCPS, BCCCP
Richard R. Furman, MD
Javier Pinilla, MD, PhD
Managing B-Cell Lymphomas in the Second-Line Setting: The Role of CAR T-Cell Therapy
Jennifer Caudle, DO
Sarah Rutherford, MD
Best Practices for Utilizing Shared Decision-Making in CLL Care
Adam Kittai, MD
B-Cell Lymphoma Care: Overcoming Challenges in the Second-Line Setting
Matthew Lunning, DO, FACP
Maximizing B-Cell Lymphoma Outcomes with CAR T-Cell Therapy and Personalized Care
Tara Graff, DO, MS
Sequencing CLL Therapies: A Guide to First-Line, Second-Line, and Beyond
Seema A. Bhat, MD
Joanna Rhodes, MD, MSCE
Relapsed/Refractory CLL Care: Tailoring Treatment and Addressing Adverse Events
CLL Treatment: Managing Uncertainty Through Effective Communication
John C. Byrd, MD
Monitoring Treatment Reponses in CLL: A Review of Key Protocols
Lindsey Roeker, MD
The CLL Landscape: A Look at Current and Future Therapies
John Russell, MD
Andrew H. Lipsky, MD
Personalizing Relapsed/Refractory CLL Care: Key Factors to Consider
AEGEAN Trial: The Role of Perioperative Durvalumab in NSCLC
Cracking the CRS Code in Myeloma: Insights from a Comprehensive Case Review
Caitlin Costello, MD
Sagar Lonial, MD, FACP
Treating mCRPC with Lutetium-177 and Radium-223: Expert Insights
Alan Bryce, MD
Cannabis Extract and Melanoma: Insights into Cell Death Mechanisms
A Roadmap to Safe and Effective Bispecific Antibody Use in Myeloma: Mitigating and Managing Adverse Events
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We’re glad to see you’re enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.